| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.005 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |